Adjuvant Nivolumab (Nivo) Vs Ipilimumab (Ipi) In Resected Stage Iii/Iv Melanoma: 4-Y Recurrence-Free And Overall Survival (Os) Results From Checkmate 238J. Weber,M. Del Vecchio, M. Mandala,H. Gogas,A. M. Arance Fernandez,S. Dalle,C. L. Cowey,M. Schenker,J-J. Grob,V. Chiarion Sileni,I. Marquez-Rodas,M. O. Butler,M. Maio, M. Middleton,L. De La Cruz Merino,M. Lobo,V. De Pril,J. Larkin,P. A. AsciertoAnnals of Oncology（2020）引用 8|浏览57暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
